Last updated: July 9, 2026
Sponsor: Massachusetts General Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lung Injury
Respiratory Failure
Treatment
Objectively monitoring thoracoabdominal asynchrony
Clinical Study ID
NCT04626154
2019P001411
Ages 28-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patients 28-days to 17-years of age
who have respiratory distress and those who do not have respiratory distress
Exclusion
Exclusion Criteria:
Hardware, clinical care, or dermal injury that would preclude the application of TAA device
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Objectively monitoring thoracoabdominal asynchrony
Phase:
Study Start date:
October 16, 2020
Estimated Completion Date:
June 01, 2029
Study Description
Connect with a study center
Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.